Follica doesn\'t need FDA Approval- Proof of concept involving 15 patients

» » So what’s the bottom line? Is experimenting with some Arava pills
» » (Leflunomide) a dumb idea, or not? Any obvious roadblocks?
»
» Leflunomide does nothing by itself. It needs to be converted to its active
» form to have any effect. The question is whether the skin has the ability
» to perform this conversion.

I’d kinda lean toward just taking it. Its just ten days, and its an anti-arthritis drug.

Yeah, that’s what I’m thinking too. It’s not like we’re talking about AZT here.

» Says who? a marketing journalist?
»
» »
» » Because the components of the system are
» » already approved, the regulatory path is pretty straightforward, and
» » Follica can perform human studies without jumping through a lot of
» » governmental hoops. That’s exactly what the company plans to do with
» the
» » money it has just raised. A proof of concept study involving 15 to 20
» » patients (Follica has no shortage of volunteers, as several hundred
» people
» » sent in e-mails when word of Cotsarelis’s work reached the public)
» should
» » begin in the next few months. The trial has several phases, however,
» and
» » Zohar cautions that final data won’t be in for at least a year. So
» don’t
» » pull your hair out waiting for results.